Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 2821 AL 2835

Informant-based assessment instruments for dementia in people with intellectual disability: A systematic review and standardised evaluation

Zeilinger EL, Zrnic Novakovic I, Komenda S, Franken F, Sobisch M, Mayer AM, Neumann LC, Loosli SV, Hoare S, Pietschnig J.

Res Dev Disabil. 2022 Feb;121:104148. doi: 10.1016/j.ridd.2021.104148. Epub 2021 Dec 27.

Impaired performances on the category cued memory test in mild Alzheimer's disease and dementia with Lewy bodies: A comparative validity study

Vogel A, Mellergaard C, Waldemar G, Frederiksen KS.

Appl Neuropsychol Adult. 2024 Jul-Aug;31(4):323-328. doi: 10.1080/23279095.2021.2021413. Epub 2021 Dec 27.

Thyroid Disorders and Development of Cognitive Impairment: A Review Study

Khaleghzadeh-Ahangar H, Talebi A, Mohseni-Moghaddam P.

Neuroendocrinology. 2022;112(9):835-844. doi: 10.1159/000521650. Epub 2021 Dec 28.

Agreement Between Automated and Manual MRI Volumetry in Alzheimer's Disease: A Systematic Review and Meta-Analysis

Quek YE, Fung YL, Cheung MW, Vogrin SJ, Collins SJ, Bowden SC.

J Magn Reson Imaging. 2022 Aug;56(2):490-507. doi: 10.1002/jmri.28037. Epub 2021 Dec 29.

Cognitive Decline and Risk of Dementia in Individuals With Heart Failure: A Systematic Review and Meta-analysis

Vishwanath S, Qaderi V, Steves CJ, Reid CM, Hopper I, Ryan J.

J Card Fail. 2022 Aug;28(8):1337-1348. doi: 10.1016/j.cardfail.2021.12.014. Epub 2021 Dec 29.

Association of Motoric Cognitive Risk Syndrome with Cardiovascular and Noncardiovascular Factors: A Systematic Review and Meta-Analysis

Iqbal K, Hasanain M, Ahmed J, Iqbal A, Rathore SS, Monis A, Baig MD, Ul Haq ZG.

J Am Med Dir Assoc. 2022 May;23(5):810-822. doi: 10.1016/j.jamda.2021.11.035. Epub 2021 Dec 31.

Genetic Risk Factors for Alzheimer's Disease in Racial/Ethnic Minority Populations in the U.S.: A Scoping Review

Rubin L, Ingram LA, Resciniti NV, Ashford-Carroll B, Leith KH, Rose A, Ureña S, McCollum Q, Friedman DB.

Front Public Health. 2021 Dec 24;9:784958. doi: 10.3389/fpubh.2021.784958. eCollection 2021.

The Impact of Exercising in the Quality of Life of People with Dementia-Alzheimer's Disease

Dimities M, Xristina F, Theodora-Elesa K, Maria C.

Adv Exp Med Biol. 2021;1339:309-315. doi: 10.1007/978-3-030-78787-5_36.

Case Report: Semantic Variant of Primary Progressive Aphasia Associated With Anti-Glial Fibrillary Acid Protein Autoantibodies

Hansen N, Stöcker W, Wiltfang J, Bartels C, Rentzsch K, Bouter C.

Front Immunol. 2022 Jan 3;12:760021. doi: 10.3389/fimmu.2021.760021. eCollection 2021.

Evaluation of memory performance in patients with brain disorders following rTMS treatment. A systematic review

Bonotis K, Anargyros K, Liaskopoulos N, Barlogianni AM.

Clin Neurophysiol. 2022 Mar;135:126-153. doi: 10.1016/j.clinph.2021.11.078. Epub 2021 Dec 24.

Mixed pathologies mimicking motor neuron disease: a case report and review of the literature

Dey A, Assaedi E, Johnston W, Kalra S, Das S.

Folia Neuropathol. 2021;59(4):403-408. doi: 10.5114/fn.2021.111486.

The effect of illiteracy on performance in screening tools for dementia: A meta-analysis

Maher C, Calia C.

J Clin Exp Neuropsychol. 2021 Dec;43(10):945-966. doi: 10.1080/13803395.2022.2040433. Epub 2022 Feb 24.

Preliminary analysis of a shortened picture version of the Free and Cued Selective Reminding Test

Rodrigo-Herrero S, Mendez-Barrio C, Bernal Sánchez-Arjona M, de Miguel-Tristancho M, Graciani-Cantisán E, Carnero-Pardo C, Franco-Macías E.

Neurologia (Engl Ed). 2022 Apr;37(3):192-198. doi: 10.1016/j.nrleng.2018.12.019. Epub 2021 Feb 26.

Physical understanding in neurodegenerative diseases

Baumard J, Lesourd M, Guézouli L, Osiurak F.

Cogn Neuropsychol. 2021 Oct-Dec;38(7-8):490-514. doi: 10.1080/02643294.2022.2071152. Epub 2022 May 13.

Cardiac Biomarkers in Stroke, Alzheimer's Disease, and Other Dementia. Are They of Use? A Brief Overview of Data from Recent Investigations

Khan S, Kamal MA.

CNS Neurol Disord Drug Targets. 2021;20(8):687-693. doi: 10.2174/1871527319666201005171003.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias